dc.contributor.author | Ostojic, Sergej M. | |
dc.date.accessioned | 2022-07-19T12:17:35Z | |
dc.date.available | 2022-07-19T12:17:35Z | |
dc.date.created | 2022-06-24T10:21:06Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Ostojic, S.M. (2022). Guanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapy. Frontiers in Human Neuroscience, 16, 5. | en_US |
dc.identifier.issn | 1662-5161 | |
dc.identifier.uri | https://hdl.handle.net/11250/3006589 | |
dc.language.iso | eng | en_US |
dc.publisher | Frontiers Media S.A. | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Guanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapy | en_US |
dc.title.alternative | Guanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapy | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | © 2022 The Author(s) | en_US |
dc.subject.nsi | VDP::Medisinske Fag: 700::Helsefag: 800 | en_US |
dc.source.pagenumber | 5 | en_US |
dc.source.volume | 16 | en_US |
dc.source.journal | Frontiers in Human Neuroscience | en_US |
dc.identifier.doi | https://doi.org/10.3389/fnhum.2022.871535 | |
dc.identifier.cristin | 2034742 | |
dc.source.articlenumber | 871535 | en_US |
cristin.qualitycode | 1 | |